[Serodiagnosis in the surveillance of the influenza virus circulation during the development of the pandemic caused by the A (H1N1)pdm09].

[Isolation of influenza A/H5N1 virus strains from poultry and wild birds in West Siberia during epizooty (July 2005) and their depositing to the state collection of viruses (August 8, 2005)]. Vopr Virusol (2006) 1.01

[Detection of the circulation of Crimean-Congo hemorrhagic fever virus in the piedmont steppes of the North Caucasus]. Vopr Virusol (2005) 0.87

[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. Vopr Virusol (1994) 0.81

[The 24 May, 2009 isolation of the first A/IIV-Moscow/01/2009 (H1N1)swl strain similar to swine A(H1N1) influenza virus from the first Moscow case detected on May 21, 2009, and its deposit in the state collection of viruses (SCV No. 2452 dated May 24, 2009)]. Vopr Virusol (2009) 0.81

[Detection of amino acid substitutions of asparaginic acid for glycine and asparagine at the receptor-binding site of hemagglutinin in the variants of pandemic influenza A/H1N1 virus from patients with fatal outcome and moderate form of the disease]. Vopr Virusol (2010) 0.81

[A possible association of fatal pneumonia with mutations of pandemic influenza A/H1N1 sw1 virus in the receptor-binding site of the HA1 subunit]. Vopr Virusol (2010) 0.79

Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses. Vaccine (1990) 0.79

[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3]. Zh Mikrobiol Epidemiol Immunobiol (2009) 0.78

[Highly pathogenic influenza A/H5N1 virus-caused epizooty among mute swans (Cygnus olor) in the lower estuary of the Volga River (November 2005)]. Vopr Virusol (2006) 0.78

[Circulation of viruses of the California serocomplex (Bunyaviridae, Bunyavirus) in the central and southern parts of the Russian plain]. Vopr Virusol (1998) 0.78

New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine. Bull Exp Biol Med (2012) 0.77

[Efficacy of ingavirin in adults with influenza]. Ter Arkh (2009) 0.77

[New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine]. Vopr Virusol (2011) 0.77

[A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children]. Vopr Virusol (1992) 0.77

[Population interactions of West Nile virus (Flaviviridae, Flavivirus) with arthropode vectors, vertebrates, humans in the middle and low belts of Volga delta in 2001-2006]. Vopr Virusol (2009) 0.77

Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88. Vaccine (1993) 0.77

[Evaluation of the efficacy of wiferon and arbidol in adult influenza]. Vopr Virusol (2008) 0.76

[Variability of hemagglutinin from strains of influenza virus A (H3N2), isolated in Russian from 1989 to 1999]. Vopr Virusol (2000) 0.76

[Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years]. Vopr Virusol (1996) 0.76

[Monoclonal antibodies with high virus-neutralizing activity against pandemic influenza virus A/llV-Moscow/01/2009 (H1N1)swl]. Vopr Virusol (2011) 0.75

[The clinico-laboratory characteristics of cases of diseases connected with viruses of the California encephalitis complex in the inhabitants of Moscow]. Zh Mikrobiol Epidemiol Immunobiol (1989) 0.75

[Characteristics of epidemiological strains of influenza A virus (H3N2) isolate in 1997-1999. Virus A/Moscow/10/99--a candidate to become the vaccine strain]. Vopr Virusol (2000) 0.75

[Effect of Zanamivir substance on infection induced by highly pathogenic avian influenza A/H5N1 in cell cultures]. Vopr Virusol (2011) 0.75

[Interaction of influenza A and B viruses with nanodiamond-based sorbents]. Vopr Virusol (2012) 0.75

[Comparative study of carbon nanotubes and polymer composites with silver as sorbents of the influenza A and B viruses]. Vopr Virusol (2015) 0.75

[Epidemic strains influenza viruses A and B in the 2005-2006 season in Russia]. Vopr Virusol (2008) 0.75

[The properties of the epidemic influenza viruses A and B strains circulating in Russia in the 2004-2005 epidemic season]. Vopr Virusol (2007) 0.75

[The peculiarities of the influenza epidemics in some areas of Russia during 2012-2013 season. The influenza A (H1N1) pdm09 virus domination in European countries]. Vopr Virusol (2014) 0.75

[The choice of the optimal schedules in the vaccination procedure against influenza in elderly subjects]. Zh Mikrobiol Epidemiol Immunobiol (1998) 0.75

[Evaluation of the immunogenic and reactogenic properties of vaccine "Euvax B" in persons aged 16-18 years in different geographical zones of Russia]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75

[Monitoring of the sensitivity of epidemic influenza virus strains isolated in Russia to etiotropic chemical agents]. Vopr Virusol (2009) 0.75

[Contribution of D I Ivanovsky Research Institute of Virology to monitoring influenza viruses during epidemics and 2009 pandemic in Russia]. Vestn Ross Akad Med Nauk (2011) 0.75

[Evaluation of the efficiency of differential diagnosis of influenza by multiplex real-time polymerase chain reaction]. Vopr Virusol (2012) 0.75

[Epizooty caused by high-virulent influenza virus A/H5N1 of genotype 2.2 (Qinghai-Siberian) among wild and domestic birds on the paths of fall migrations to the north-western part of the Azov Sea basin (Krasnodar Territory)]. Vopr Virusol (2008) 0.75

[The specific features of the cocirculation of influenza viruses in the 2010-2011 postpandemic period according to the results of activities of the D. I. Ivanovsky Research Institute of Virology, Ministry of Health and Social Development of Russia]. Vopr Virusol (2012) 0.75

[Information of the Center for Ecology and Epidemiology of Influenza, D. I. Ivanovsky Research Institute of Virology, Russian Academy of Medical Sciences, on the results of the 2009-2010 influenza and acute respiratory viral infection epidemic season (at week 40 of 2009 to week 22 of 2010) in the world and Russia]. Vopr Virusol (2011) 0.75

[Efficacy of anti-neuraminidase drugs application during and after an influenza pandemic]. Vopr Virusol (2013) 0.75

[Pathogenicity of West Nile virus: molecular markers]. Vopr Virusol (2010) 0.75

[Sensitivity of the epidemic and pandemic influenza virus strains to zanamivir (Relenze) in in vitro experiments]. Vopr Virusol (2011) 0.75

[Viferon efficacy in influenza in adult patients]. Antibiot Khimioter (2009) 0.75

[Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season]. Vopr Virusol (2007) 0.75

[Serological monitoring of arbovirus infections in the estuary of the Kuban River (the 2006-2007 data)]. Vopr Virusol (2008) 0.75

[Taxonomic structure of Orthomyxoviridae: current views and immediate prospects]. Vestn Ross Akad Med Nauk (2011) 0.75

[Viral sorption on polyaniline, carbon nanotubes and their based nanocomposites]. Vopr Virusol (2011) 0.75

[Isolation of the Chikungunya virus in Moscow from the Indonesian visitor (September, 2013)]. Vopr Virusol (2014) 0.75

[Diseases associated with viruses of the California encephalitis serogroup, in Russia]. Vopr Virusol (1998) 0.75

[Trends in the spread of pandemic influenza A(H1N1) swl in the Far East in 2009]. Vopr Virusol (2010) 0.75

[Comparative evaluation of the therapeutic effectiveness of virazole and remantadine in patients with influenza caused by A(H3N2) and B viruses]. Vopr Virusol (1985) 0.75

[ West Nile fever among residents of the Astrakhan region in 2002]. Vopr Virusol (2003) 0.75

[Efficiency of the influenza A and B viruses isolation from nasopharyngeal swabs taken in the test tubes Sigma-Virocult (M40 Compliant, Sigma Virocult) and Virocult (M40 Compliant, Virocult) in 2010-2011 epidemic season]. Vopr Virusol (2013) 0.75

[Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence]. Mol Gen Mikrobiol Virusol (2008) 0.75

[The spread and biological properties of epidemic influenza viruses A and B strains circulating in the 2006-2007 season in Russia]. Vopr Virusol (2008) 0.75

[Complex environmental and virological monitoring in the Primorye Territory in 2003-2006]. Vopr Virusol (2007) 0.75

[Etiology of fatal pneumonia caused by influenza A(H1N1)pdm2009 virus during the pandemic in Russia]. Vopr Virusol (2013) 0.75

[Monoclonal antibodies to highly pathogenic avian influenza A(H5N1) strain isolated in the Russian Federation: development and properties]. Vopr Virusol (2008) 0.75

[Spread and properties of epidemic influenza A and B virus strains accountable for morbidity in Russia during 1999-2002]. Vopr Virusol (2003) 0.75

[Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease]. Ter Arkh (2011) 0.75

[Sister of mercy L. V. Dobrova--a participant in the revolutionary events of 1905 in the Don Basin]. Med Sestra (1989) 0.75

[Correlation between the receptor specificity of pandemic influenza A (H1N1)pdm09 virus strains isolated in 2009-2011 and the structure of the receptor-binding site and the probability of fatal primary viral pneumonia]. Vopr Virusol (2012) 0.75

[Development of the influenza epidemic in season 2011-2012 in some areas of Russia: results of activity of the Influenza Etiology and Epidemiology Center of the Ivanovsky Institute of Virology]. Vopr Virusol (2013) 0.75

[Etiotropic therapy of influenza: lessons from the last pandemic]. Vestn Ross Akad Med Nauk (2011) 0.75

[The 2013-2014 epidemic season. Hospital monitoring and antiviral therapy for influenza ]. Ter Arkh (2014) 0.75

[Natural killer activity in influenza patients]. Vopr Virusol (1988) 0.75

[Viferon suppositories in the treatment of influenza in adults]. Antibiot Khimioter (2008) 0.75

[Efficacy of ozeltamivir (Tamiflu) in adult influenza on the epidemic rise of morbidity in Russia in the 2006-2007 season]. Vopr Virusol (2008) 0.75

[Mosquito-borne arboviruses in the Baikal region]. Vopr Virusol (1995) 0.75

[Isolation of highly pathogenic avian influenza (HPAI) A/5H5N1 strains from wild birds in the epizootic outbreak on the Ubsu-Nur Lake (June 2006) and their incorporation to the Russian Federation State Collection of viruses (July 3, 2006)]. Vopr Virusol (2007) 0.75

[Detection of conservative and variable epitopes of the pandemic influenza virus A(H1N1)pdm09 hemagglutinin using monoclonal antibodies]. Vopr Virusol (2014) 0.75

[Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013]. Vopr Virusol (2015) 0.75

[Variability and prevalence characteristics of Influenza A virus (H1N1) in period 1990-1998]. Vopr Virusol (2001) 0.75

[The characteristics of epidemic influenza A and B virus strains circulating in Russia during the 2007-2008 season]. Vopr Virusol (2009) 0.75

[Molecular genetic studies of the susceptibility of epidemic influenza A(H1N1) virus strains isolated in the 2006-2009 seasons in Russia to oseltamivir (Tamiflu)]. Vopr Virusol (2011) 0.75

[Significance of viruses of antigen complex of California encephalitis in pathology]. Klin Med (Mosk) (1989) 0.75

[Arborviruses of the California encephalitis serogroup 1N Russia and their contribution to infectious pathology]. Vestn Ross Akad Med Nauk (2011) 0.75

[Spread of new pandemic influenza A(H1N1)v virus in Russia]. Vopr Virusol (2010) 0.75